High-sensitivity Troponin-T: Difference between revisions
From Guide to YKHC Medical Practices
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
The U.S. FDA approved the first high-sensitivity troponin assay, the Roche Diagnostics ''Elecsys Troponin T (TnT) Gen 5 Stat'' test, in March 2017. | The U.S. FDA approved the first high-sensitivity troponin assay, the Roche Diagnostics ''Elecsys Troponin T (TnT) Gen 5 Stat'' test, in March 2017. | ||
Yukon-Kuskokwim Delta Regional Hospital (YKDHR) adopted this high-sensitivity cardiac troponin-T (Hs- | Yukon-Kuskokwim Delta Regional Hospital (YKDHR) adopted this high-sensitivity cardiac troponin-T (Hs-cTnT) assay on November 12, 2019. | ||
The high-sensitivity and contemporary troponin-T assays can be distinguished by the units in which they are reported: Hs- | The high-sensitivity and contemporary troponin-T assays can be distinguished by the units in which they are reported: Hs-cTnT is reported in ng/'''L''' whereas the contemporary assay (cTnT) is reported in ng/'''mL'''. | ||
== Helpful Links == | == Helpful Links == | ||
Revision as of 07:44, 2 December 2019
The U.S. FDA approved the first high-sensitivity troponin assay, the Roche Diagnostics Elecsys Troponin T (TnT) Gen 5 Stat test, in March 2017.
Yukon-Kuskokwim Delta Regional Hospital (YKDHR) adopted this high-sensitivity cardiac troponin-T (Hs-cTnT) assay on November 12, 2019.
The high-sensitivity and contemporary troponin-T assays can be distinguished by the units in which they are reported: Hs-cTnT is reported in ng/L whereas the contemporary assay (cTnT) is reported in ng/mL.
